Health 2030 Genome Center, Switzerland
A Platform for the Future of Precision Medicine
Genomic analysis is at the forefront of research and clinical developments around the world. Leading countries in research including the USA and the UK have made large public and private investments to develop sequencing capacity and the necessary data analysis tools for research and clinical use. As genome analysis becomes commonplace in research and clinics, Switzerland has much to offer in terms of scientific strength, quality of its healthcare system (including universal coverage) and detailed patient phenotyping.
Health 2030 Genome Center
The Health 2030 Genome Center is a multi-institutional hub established to promote genomic medicine in Switzerland. The Genome Center is the genomic medicine arm of the Health 2030 initiative (health2030.ch), whose goal is to promote Swiss personalized medicine (initiated by: EPFL, UNIGE, CHUV, HUG, UNIL, InselSpital and UNIBE).
The Genome Center was conceived as a hub for genetics and genomics research to foster collaboration, to increase communication and to promote the sharing of ideas, allowing for the long-term development of major initiatives. In addition, the Genome Center increases the impact of the sequencing facility itself as new developments and projects are discussed and designed in real time through daily interactions of all stakeholders.
More broadly, the Genome Center aims to advance knowledge of disease pathogenesis, improving human health through preventive, diagnostic and therapeutic approaches, thereby realizing the social and economic benefits of genomics.
www.health2030.ch/genome